Kindeva Appoints Melanie Cerullo as Chief Quality Officer

• Kindeva has appointed Melanie Cerullo as Chief Quality Officer to lead its global quality, compliance, and regulatory strategy.

• Cerullo brings nearly 30 years of experience from CDMOs and product innovators, including roles at ReciBioPharm and Arranta Bio.

Kindeva, a global CDMO and drug delivery specialist, has announced the appointment of Melanie Cerullo as its new Chief Quality Officer. The move is aimed at reinforcing the company’s quality, compliance, and regulatory approach as it expands its global operations.

Cerullo joins the firm with close to 30 years of experience in the pharmaceutical sector, including leadership positions across product innovators and CDMOs. Her previous roles at ReciBioPharm, Arranta Bio, and WAVE Life Sciences covered quality assurance, regulatory compliance, and GMP manufacturing.

In her new role, Cerullo will serve on Kindeva’s Executive Leadership Team, with a remit to further develop the company’s quality systems and regulatory readiness. This includes advancing the firm’s compliance culture and capabilities across its contract manufacturing services.

“Melanie’s expertise and impressive track record in FDA, EMA, and ICH regulations will be pivotal in our mission to foster operational growth and innovation across the company,” said Milton Boyer, CEO of Kindeva.